|
17 Sep 2008 |
BT Pharma successfully closes EUR 2.8 million (USD 4M) financing round
|
|
10 Sep 2008 |
ImVisioN Therapeutics Starts Phase I Clinical Trial of IVN201 Against Cat Dander Allergy and Raises CHF 4.6 M
|
|
10 Sep 2008 |
New Phase II data show Novartis investigational Meningitis B vaccine may also protect infants six months and older
|
|
10 Sep 2008 |
Circassia Achieves Successful Phase II Clinical Results With ToleroMune(R) Anti-Allergy Technology
|
|
03 Sep 2008 |
Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program
|
|
03 Sep 2008 |
Phase III U.S. Pivotal Study Results on CSL Biotherapies' Afluria Published in Vaccine
|
|
28 Aug 2008 |
Intercell announces initiation of further Phase II clinical trial of V710 an investigational vaccine
|
|
28 Aug 2008 |
Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
|
|
27 Aug 2008 |
Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer
|
|
26 Aug 2008 |
Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
|
|
21 Aug 2008 |
NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
|
|
21 Aug 2008 |
VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
|
|
21 Aug 2008 |
VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
|
|
20 Aug 2008 |
BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
|
|
19 Aug 2008 |
EndoBiologics, Incorporated, and PATH Form New Collaboration to Research Vaccine Candidates Against Diarrheal Disease
|
|
16 Aug 2008 |
Cytos Biotechnology and Pfizer enter into a research, option and license agreement for certain novel vaccines for a defined number of human diseases
|
|
14 Aug 2008 |
Bioms Medical Announces Positive Interim Analysis on Phase III Trial of Dirucotide (MBP8298) For Multiple Sclerosis
|
|
07 Aug 2008 |
DOR BioPharma Announces Initiation of Second Human Clinical Trial for RiVax(TM), Its Ricin Toxin Vaccine
|
|
06 Aug 2008 |
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
|
|
05 Aug 2008 |
Bionor Immuno have started a Vacc-4x Phase IIB TOC study in US and Europe with enrollment of 345 patients.
|
|
03 Aug 2008 |
Bioms Medical Completes Patient Recruitment in Phase III U.S. Multiple Sclerosis Trial
|
|
28 Jul 2008 |
Nventa Announces Final Data From HSPE7 Phase I Cervical Dysplasia Trial
|
|
23 Jul 2008 |
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
|
|
22 Jul 2008 |
Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis
|
|
18 Jul 2008 |
Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial
|
